Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer
March 19, 2024 07:00 ET
|
Conduit Pharmaceuticals
Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer
Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe’s Leading Life Sciences Hub
March 11, 2024 07:00 ET
|
Conduit Pharmaceuticals
SAN DIEGO and LONDON, March 11, 2024 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) ("Conduit Pharmaceuticals" or "Conduit") today announced the opening of cutting-edge laboratory...
Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
January 31, 2024 08:30 ET
|
Conduit Pharmaceuticals
Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conference
November 02, 2023 08:30 ET
|
Conduit Pharmaceuticals
Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conference
Conduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656
October 11, 2023 08:30 ET
|
Conduit Pharmaceuticals
SAN DIEGO and LONDON, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit Pharmaceuticals” or “Conduit”), a multi-asset clinical-stage disease-agnostic life...
Conduit Pharmaceuticals and Murphy Canyon Acquisition Corp. Announce Completion of Business Combination
September 22, 2023 09:01 ET
|
Conduit Pharmaceuticals
SAN DIEGO, Sept. 22, 2023 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Limited (“Conduit Pharmaceuticals”), a multi-asset clinical-stage disease-agnostic life science company providing an efficient...